Use of 7-[4-(4-benzo[b]thiophene-4-yl-piperyl-1-yl)butoxy]-1H-quinoline-2-one salt and additives having ions common to the salt for the manufacture of controlled-release oral solid pharmaceutical compositions.

TW202635307APending Publication Date: 2026-09-01OTSUKA PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115118107
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-08-13
Filing Date
2020-08-13
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001075389_001
    Figure TWG2TA001075389_001
  • Figure TWG2TA001075389_002
    Figure TWG2TA001075389_002
  • Figure TWG2TA001075389_003
    Figure TWG2TA001075389_003
Patent Text Reader

Abstract

The present invention provides a method that can prevent the initial excessive release of the active ingredient and can continuously release the active ingredient at a therapeutically effective amount for a long period of time.
Need to check novelty before this filing date? Find Prior Art